Domestic medical equipment:What are the key achievements of China's domestic medical equipment industry in 2026?
Q: What are the key achievements of China's domestic medical equipment industry in 2026?
A: According to the 2026 China Medical Device Industry Development Report released by the Ministry of Industry and Information Technology, the domestic medical equipment industry achieved a market size of 1.8 trillion yuan in 2026, representing a 15.2% year-on-year growth. The self-sufficiency rate for high-end medical equipment reached 45%, up from 32% in 2023. Notably, domestic manufacturers now account for 60% of the CT scanner market and 55% of the MRI market. The report highlights breakthroughs in 3.0T superconducting MRI systems, 128-slice CT scanners, and surgical robots, with several products receiving FDA and CE certifications. The industry also filed over 12,000 invention patents in 2026, a 20% increase from the previous year. These achievements reflect the success of the 'Made in China 2025' initiative in advancing medical equipment localization and innovation.
Q: What government policies support domestic medical equipment in 2026?
A: The 2026 National Health Commission policy document 'Guidelines for Promoting Domestic Medical Equipment Application' outlines several supportive measures. First, public hospitals are required to prioritize domestic equipment in procurement when performance and quality are comparable, with a target of 70% domestic sourcing by 2028. Second, the Central Government allocated 50 billion yuan in 2026 for medical equipment R&D subsidies, focusing on high-end imaging, minimally invasive surgery, and AI-assisted diagnostics. Third, the National Medical Products Administration streamlined approval processes for innovative domestic devices, reducing review time from 18 months to 12 months. Additionally, the 2026 tax reform exempts domestic medical equipment manufacturers from value-added tax on R&D expenses. The policy also encourages international collaboration while protecting intellectual property. These measures aim to reduce reliance on imports, which currently account for 55% of high-end equipment, and to foster a self-reliant medical supply chain.
Q: How competitive are domestic medical equipment products in the global market in 2026?
A: The 2026 Global Medical Device Trade Report by the World Health Organization indicates that Chinese domestic medical equipment exports reached $45 billion in 2026, a 22% increase from 2025. Chinese products now hold a 12% share of the global medical device market, up from 8% in 2023. Key competitive advantages include cost-effectiveness, rapid innovation, and strong supply chain integration. For example, domestic patient monitors and ultrasound machines are exported to over 150 countries, with a 30% market share in Southeast Asia and 15% in Europe. However, challenges remain in high-end markets: Chinese MRI and CT scanners have only a 5% share in the US and EU due to regulatory hurdles and brand perception. The report notes that 2026 saw increased international certification, with 200 domestic products receiving CE marks and 50 getting FDA approvals. Overall, domestic equipment is transitioning from low-end to mid-to-high-end global competitiveness.
Q: What are the main challenges facing domestic medical equipment in 2026?
A: Despite progress, the 2026 China Medical Device Industry White Paper identifies several challenges. First, core component dependency: 70% of high-end sensors and 60% of precision optical parts are still imported, exposing supply chain vulnerabilities. Second, talent shortage: the industry needs 100,000 skilled engineers annually, but only 60,000 are available, particularly in AI and robotics. Third, clinical validation gaps: domestic equipment often lacks long-term clinical data compared to international brands, affecting hospital adoption. Fourth, intellectual property disputes: in 2026, Chinese firms faced 50 new patent infringement lawsuits abroad, up 25% from 2025. Fifth, market fragmentation: over 5,000 domestic manufacturers, but only 10% have annual revenues exceeding 1 billion yuan, limiting R&D investment. The white paper recommends increased collaboration between hospitals, universities, and enterprises, and calls for a national medical equipment innovation fund to address these issues and achieve 70% self-sufficiency by 2030.
Dialogue about
Common scenarios of "Domestic medical equipment"
【Reporter】 Good morning, Dr. Li. Thank you for joining us today. Domestic medical equipment has been a hot topic recently. Can you give us an overview of the current landscape?
【Dr. Li】 Good morning. Yes, domestic medical equipment has seen remarkable growth. In the past, hospitals relied heavily on imports, but now many domestic brands are competing globally. The quality and technology have improved significantly.
【Reporter】 That's impressive. What are some key factors driving this growth?
【Dr. Li】 Several factors: government policies supporting local innovation, increased R&D investment by companies, and the need for cost-effective solutions in healthcare. Also, the pandemic highlighted the importance of self-sufficiency in medical supplies.
【Reporter】 Can you name some specific examples of domestic medical equipment that have gained prominence?
【Dr. Li】 Certainly. For imaging, companies like United Imaging and Neusoft Medical produce MRI and CT scanners that rival imported ones. In monitoring, Mindray is a global leader. For ventilators, brands like Aeonmed have been crucial during COVID-19.
【Reporter】 How do domestic products compare to imported ones in terms of quality and reliability?
【Dr. Li】 In many cases, they are on par or even better. Domestic companies often tailor products to local needs and offer faster after-sales service. However, for some high-end equipment like certain surgical robots, imports still dominate, but the gap is narrowing.
【Reporter】 What challenges do domestic medical equipment manufacturers face?
【Dr. Li】 Challenges include stringent regulatory approvals, competition from established international brands, and the need for continuous innovation. Also, some hospitals still prefer imported brands due to perceived prestige, but that's changing.
【Reporter】 How has the government supported the domestic medical equipment industry?
【Dr. Li】 The government has implemented policies like 'Made in China 2025' to boost high-tech industries, provided subsidies for R&D, and streamlined approval processes. They also encourage hospitals to purchase domestic equipment through procurement guidelines.
【Reporter】 What about the export market? Are Chinese medical devices being sold internationally?
【Dr. Li】 Absolutely. Chinese medical devices are exported to over 200 countries. Companies like Mindray and United Imaging have significant international presence. They are especially popular in emerging markets for their性价比 (cost-effectiveness).
【Reporter】 How does the COVID-19 pandemic impact the domestic medical equipment industry?
【Dr. Li】 The pandemic was a catalyst. It increased demand for ventilators, monitors, and diagnostic equipment. Domestic manufacturers ramped up production and gained trust. It also accelerated digital health solutions like telemedicine.
【Reporter】 What does the future hold for domestic medical equipment?
【Dr. Li】 The future looks bright. With advancements in AI, robotics, and telemedicine, domestic companies are well-positioned. We'll see more integration of smart technologies and personalized medicine. Also, increased collaboration between hospitals and manufacturers will drive innovation.
【Reporter】 Any final thoughts for our audience?
【Dr. Li】 Yes, I encourage healthcare professionals to give domestic equipment a fair chance. They are reliable, cost-effective, and continuously improving. Supporting local innovation ultimately benefits our healthcare system and economy.
